Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure

M Sarnak, 2003, American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention, Circulation, 17, 2154, 10.1161/01.CIR.0000095676.90936.80

L Van Gaal, 2006, Mechanisms linking obesity with cardiovascular disease, Nature, 7121, 875, 10.1038/nature05487

J Malyszko, 2002, Leptin correlates with some hemostatic parameters in CAPD patients, Nephron, 3, 721, 10.1159/000064074

J Malyszko, 2005, Markers of endothelial cell activation/injury: CD146 and thrombomodulin are related to adiponectin in kidney allograft recipients, Am J Nephrol, 3, 203, 10.1159/000085827

J Malyszko, 2007, Adipokines, Linking Adipocytes and Vascular Function in Hemodialyzed Patients, May Also Be Possibly Related to CD146, a Novel Adhesion Molecule, Clin Appl Thromb Hemost

J Malyszko, 2004, Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients, J Clin Endocrinol Metab, 9, 4620, 10.1210/jc.2004-0387

A Fukuhara, 2005, Visfatin: a protein secreted by visceral fat that mimies the effects of insulin, Science, 5708, 426, 10.1126/science.1097243

M Yilmaz, 2008, Serum visfatin concentration and endothelial dysfunction in chronic kidney disease, Nephrol Dial Transplant, 3, 959

M Kleinz, 2005, Emerging roles of apelin in biology and medicine, Pharmacol Ther, 2, 198, 10.1016/j.pharmthera.2005.04.001

J Boucher, 2005, Apelin, a newly identified adipokine up-regulated by insulin and obesity, Endocrinology, 4, 1764, 10.1210/en.2004-1427

V Panichi, 2001, C reactive protein in patients with chronic renal diseases, Ren Fail, 3-4, 551, 10.1081/JDI-100104737

P Stenvinkel, 1999, High serum hyaluronan indicates poor survival in renal replacement therapy, Am J Kidney Dis, 6, 1083, 10.1016/S0272-6386(99)70014-4

S Chung, 2001, Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis, Nephrol Dial Transplant, 11, 2240, 10.1093/ndt/16.11.2240

R Pecoits-Filho, 2003, Associations between circulating inflammatory markers and residual renal function in CRF patients, Am J Kidney Dis, 6, 1212, 10.1016/S0272-6386(03)00353-6

M Chen, 2006, Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus, J Clin Endocrinol Metab, 1, 295, 10.1210/jc.2005-1475

A Hammarstedt, 2006, Visfatin is an adipokine, but it is not regulated by thiazolidinediones, J Clin Endocrinol Metab, 3, 1181, 10.1210/jc.2005-1395

J Malyszko, 2006, Apelin and cardiac function in hemodialyzed patients: possible relations?, Am J Nephrol, 2, 121, 10.1159/000092122

A Gearing, 1992, Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance, Ann NY Acad Sci, 667, 324, 10.1111/j.1749-6632.1992.tb51633.x

L Malatino, 2007, Circulating E-selectin as a risk marker in patients with end-stage renal disease, J Intern Med, 4, 479, 10.1111/j.1365-2796.2007.01841.x

A Japp, 2008, The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential, Biochem Pharmacol, 10, 1882, 10.1016/j.bcp.2007.12.015

A Sheikh, 2008, In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure, Am J Physiol Heart Circ Physiol, 1, H88, 10.1152/ajpheart.00935.2007

M Bonomini, 1998, Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients, Nephron, 4, 399, 10.1159/000045084

J Slupsky, 1998, Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40, Thromb Haemost, 6, 1008

S Ognjanovic, 2002, Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes, Am J Obstet Gynecol, 4, 1051, 10.1067/mob.2002.126295

A Moschen, 2007, Visfatin, an adipocytokine with proinflammatory and immunomodulating properties, J Immunol, 3, 1748, 10.4049/jimmunol.178.3.1748

K Oki, 2007, Circulating visfatin level is correlated with inflammation, but not with insulin resistance, Clin Endocrinol (Oxf), 5, 796, 10.1111/j.1365-2265.2007.02966.x

J Axelsson, 2007, Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD, Am J Kidney Dis, 2, 237, 10.1053/j.ajkd.2006.11.021

J Axelsson, 2006, Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance, Kidney Int, 3, 596, 10.1038/sj.ki.5000089

M Yilmaz, 2008, Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin, Nephrol Dial Transplant, 5, 1621, 10.1093/ndt/gfm828